Matches in Wikidata for { <http://www.wikidata.org/entity/Q38078598> ?p ?o ?g. }
Showing items 1 to 71 of
71
with 100 items per page.
- Q38078598 description "article científic" @default.
- Q38078598 description "article scientifique" @default.
- Q38078598 description "articol științific" @default.
- Q38078598 description "articolo scientifico" @default.
- Q38078598 description "artigo científico" @default.
- Q38078598 description "artigo científico" @default.
- Q38078598 description "artigo científico" @default.
- Q38078598 description "artikel ilmiah" @default.
- Q38078598 description "artikull shkencor" @default.
- Q38078598 description "artículo científico" @default.
- Q38078598 description "artículu científicu espublizáu en 2013" @default.
- Q38078598 description "bilimsel makale" @default.
- Q38078598 description "scienca artikolo" @default.
- Q38078598 description "scientific article published on 30 January 2013" @default.
- Q38078598 description "scientific article published on 30 January 2013" @default.
- Q38078598 description "scientific article published on 30 January 2013" @default.
- Q38078598 description "vedecký článok" @default.
- Q38078598 description "vetenskaplig artikel" @default.
- Q38078598 description "videnskabelig artikel" @default.
- Q38078598 description "vitenskapelig artikkel" @default.
- Q38078598 description "vitskapeleg artikkel" @default.
- Q38078598 description "vědecký článek" @default.
- Q38078598 description "wetenschappelijk artikel" @default.
- Q38078598 description "wissenschaftlicher Artikel" @default.
- Q38078598 description "наукова стаття, опублікована в січні 2013" @default.
- Q38078598 description "научная статья" @default.
- Q38078598 description "научни чланак" @default.
- Q38078598 description "מאמר מדעי" @default.
- Q38078598 description "مقالة علمية نشرت في 30 يناير 2013" @default.
- Q38078598 description "বৈজ্ঞানিক নিবন্ধ" @default.
- Q38078598 name "Oral and intravenously administered mTOR inhibitors for metastatic renal cell carcinoma: pharmacokinetic considerations and clinical implications." @default.
- Q38078598 name "Oral and intravenously administered mTOR inhibitors for metastatic renal cell carcinoma: pharmacokinetic considerations and clinical implications." @default.
- Q38078598 type Item @default.
- Q38078598 label "Oral and intravenously administered mTOR inhibitors for metastatic renal cell carcinoma: pharmacokinetic considerations and clinical implications." @default.
- Q38078598 label "Oral and intravenously administered mTOR inhibitors for metastatic renal cell carcinoma: pharmacokinetic considerations and clinical implications." @default.
- Q38078598 prefLabel "Oral and intravenously administered mTOR inhibitors for metastatic renal cell carcinoma: pharmacokinetic considerations and clinical implications." @default.
- Q38078598 prefLabel "Oral and intravenously administered mTOR inhibitors for metastatic renal cell carcinoma: pharmacokinetic considerations and clinical implications." @default.
- Q38078598 P1433 Q38078598-D2B0CFA7-8426-463E-AAD7-2368871B8E45 @default.
- Q38078598 P1476 Q38078598-5CA6A18B-ED54-43EA-A807-88C17DDAC2A2 @default.
- Q38078598 P2093 Q38078598-FABCBB09-C7AD-45E5-9B1F-1AB908F70E90 @default.
- Q38078598 P304 Q38078598-5F1291CA-0EF9-4495-9A04-3C0C28574AFA @default.
- Q38078598 P31 Q38078598-B588D5C2-E60D-435F-9066-8F960FF93041 @default.
- Q38078598 P31 Q38078598-afa73332-f0bf-4a28-871d-12e905d7f8d2 @default.
- Q38078598 P356 Q38078598-16F4EBFE-F8C0-4CBD-84EA-A93247C904B4 @default.
- Q38078598 P433 Q38078598-F736CD14-E6B0-4498-8650-3DE77147C03D @default.
- Q38078598 P478 Q38078598-3A217259-596A-43D8-9E19-8E8D22A61344 @default.
- Q38078598 P50 Q38078598-4B2A38C9-A1C3-4652-A848-99A1DA5E3F5D @default.
- Q38078598 P50 Q38078598-709FC0B2-93E3-4AAA-AD32-A5E29F62FAFD @default.
- Q38078598 P577 Q38078598-AAD4A924-8032-456B-91E3-FC7A06BDE160 @default.
- Q38078598 P698 Q38078598-4DD5DEDB-F264-44AD-AC6C-66EB19373E88 @default.
- Q38078598 P921 Q38078598-189C7C1C-FA7E-4F2E-A4F3-D01F67B82478 @default.
- Q38078598 P921 Q38078598-5AC64F94-03B0-443E-9E94-676AE8A696AA @default.
- Q38078598 P921 Q38078598-E4391324-F8C5-42F6-BFAD-DB7BBBFB7D89 @default.
- Q38078598 P356 J.CTRV.2012.12.012 @default.
- Q38078598 P698 23375248 @default.
- Q38078598 P1433 Q1955762 @default.
- Q38078598 P1476 "Oral and intravenously administered mTOR inhibitors for metastatic renal cell carcinoma: pharmacokinetic considerations and clinical implications" @default.
- Q38078598 P2093 "Joseph P Boni" @default.
- Q38078598 P304 "784-792" @default.
- Q38078598 P31 Q13442814 @default.
- Q38078598 P31 Q7318358 @default.
- Q38078598 P356 "10.1016/J.CTRV.2012.12.012" @default.
- Q38078598 P433 "7" @default.
- Q38078598 P478 "39" @default.
- Q38078598 P50 Q56548743 @default.
- Q38078598 P50 Q67479522 @default.
- Q38078598 P577 "2013-01-30T00:00:00Z" @default.
- Q38078598 P698 "23375248" @default.
- Q38078598 P921 Q1164529 @default.
- Q38078598 P921 Q19000948 @default.
- Q38078598 P921 Q323936 @default.